Abstract Submission

The International Narcotics Research Conference 2010
Malmö, Sweden

Dates: July 11 (Sun) to July 16 (Fri), 2010

SPEAKERS please note that Symposium lectures are scheduled for 20 min each and hot topics for 10 min.

 


Abstract submission deadline is April 1, 2010

As many active participants as possible are welcome at INRC meetings. Abstracts should be provided for poster presentations, as well as all oral presentations including Symposia, Founder, and Plenary lectures. If you haven't been invited to give an oral presentation, please plan on preparing a poster. Some authors will be invited to give a short oral presentation after submission of an abstract.

Posters: To accommodate all posters on display for the duration of the meeting, poster boards must be no greater than a maximum size. The the maximum size for each poster is given below:

poster size: 100 cm wide x 140 cm tall (length 100 cm and height 140 cm).

for those countries still using non-metric units:

poster size: 38 inches wide x 55 inches tall (length 38 inches and height 55 inches).

 

 

Pushpins to mount the posters will be provided.

  You will find your abstract number in the abstract book which you will obtain when registering for the meeting in Malmo or earlier on the INRC website.

Abstract Submission Instructions

Abstracts may only be submitted electronically for this meeting. Please note the abstract submission deadline of April 1, 2010!

Please type up your abstract according to this sample:

INVOLVEMENT OF GLT-1, A GLIAL GLUTAMATE TRANSPORTER, IN PHYSICAL AND PSYCHOLOGICAL MORPHINE DEPENDENCE
T. Nakagawa (1), T. Ozawa (1), Y. Sekiya (1), H. Ueda (2), M. Satoh (1) (1)Dept. of Mol. Pharmacol., Grad. Sch. of Pharmaceut. Sci., Kyoto Univ., Kyoto, Japan, (2)Dept. of Mol. Pharmacol. and Neurosci., Sch. of Pharmaceut. Sci.,Nagasaki Univ., Nagasaki, Japan

We previously reported the changes in the expression of the glial glutamate transporter GLT-1 mRNA in some brain regions of morphine-dependent rats. In this study, we examined the roles of GLT-1 in physical and psychological dependence on morphine......blah, blah, blah, blah, blah, blah, blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,blah, blah, blah, blah, blah, blah,...etc, etc ........................................... DON'T FORGET to acknowledge your funding source at end!!

Do NOT use Greek symbols but spell out symbols as much as possible. Use character count tools! Keep total characters (including titles, names, institutions & spaces) to no more than 1400 characters.

Please indicate a maximum of 2 keywords in your email. The following symposia are planned and additional short oral presentations will be chosen from submitted abstracts.

1. Novel opioid peptide agonists and antagonists
2. Transcription and epigenetics of opioid peptide genes
3. Ligand-directed Signaling and Functional Selectivity
4. Opioids in neuropathic pain - Preclinical part
5. Opioids in neuropathic pain - Clinical part
6. Opioids & stem cell research - Recent progress in the stem cell biology and adult neurogenesis
7. Opioids, Incentive Drive and Habit
8. Opioid addiction Clinical aspects
9. Opioids in alcohol addiction - Preclinical research
10. Opioids in addiction to alcohol and central stimulants - Clinical research
11. Endogenous opioids and addiction to gambling
12. Opioids in neuroendocrinology abuse of steroids
13. Opioid and cannabinoid interaction (joint session with the ICRS)


If your email program does not allow attachments, please paste text of your abstract directly in the body of an email.

File type: Word.doc is preferred.
Font: Times or Times New Roman.
Size: No more than 1400 characters including titles, authors, and spaces.

Please indicate in the body of your email if you are willing to present an oral presentation if selected.

Symposia, Founder, and Plenary lecturers abstracts can be 2800 characters at most.

 

IMPORTANT! Please name your abstract word file with your last name,
then initials of your other names.
(for example "stevenscw.doc" for "Amynah Pradhan")

Save your abstract document as a Microsoft word doc, attach it to an email with the subject
line as "INRC Abstract", and send to Dr. Fred Nyberg at:
inrc.malmo.2010@gmail.com

 

Abstract Publication
Abstracts will be available for viewing at the INRC website and in the abstract book distributed at the Meeting.

 

As further information becomes available, announcements will be made to the INRC-L email list. If you are not already on the INRC-list server, please send your current e-mail address, full name and institutional affiliation to:

Amynah Pradhan, Ph.D.
INRC Information Officer
at:
pradhan4@uic.edu

 

 

 

Comments or suggestions can be emailed to the INRC Information Officer at:  pradhan4@uic.edu